Cidara Therapeutics (CDTX) Reports Q4 Loss of $0.88/Share

Cidara Therapeutics (NASDAQ: CDTX) reported Q4 EPS of ($0.88), versus ($0.72) reported last year. Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
• BXP Inc. (BXP) PT Raised to $70 at UBS as Earnings Outlook Accelerates
• Rush Enterprises Inc. (RUSHA) PT Raised to $85 at UBS